Literature DB >> 15082915

Growth factor regulation of cell cycle progression in mammary epithelial cells.

Malinda A Stull1, Anne M Rowzee, Aimee V Loladze, Teresa L Wood.   

Abstract

Growth factors are among the critical positive and negative regulators of cell proliferation for normal mammary/breast epithelial cells and for breast cancer cells. The mechanisms by which specific growth factors regulate the cell cycle in mammary/breast epithelial cells is beginning to be understood for several growth factor families, including the epidermal growth factor, insulin-like growth factor, and transforming growth factor-beta families. A critical issue for understanding how growth factors regulate the cell cycle in vivo is how individual factors interact with other growth factors or hormones to enhance or inhibit specific molecular targets in the cell cycle machinery. This review addresses what is currently known about how growth factors regulate the cell cycle in mammary/breast epithelial cells both individually and in coordination with other growth regulators.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15082915     DOI: 10.1023/B:JOMG.0000023585.95430.f4

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  74 in total

Review 1.  A specific role for cyclin D1 in mammary gland development.

Authors:  P Sicinski; R A Weinberg
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

2.  Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.

Authors:  A E Lenferink; J F Simpson; L K Shawver; R J Coffey; J T Forbes; C L Arteaga
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

3.  Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.

Authors:  C R Chen; Y Kang; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

4.  IGF-2 is a mediator of prolactin-induced morphogenesis in the breast.

Authors:  Cathrin Brisken; Ayyakkannu Ayyannan; Cuc Nguyen; Anna Heineman; Ferenc Reinhardt; Jian Tan; S K Dey; G Paolo Dotto; Robert A Weinberg; Tian Jan
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

5.  Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development.

Authors:  W Ruan; D L Kleinberg
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

6.  Somatomedin-C substitutes for insulin for the growth of mammary epithelial cells from normal virgin mice in serum-free collagen gel cell culture.

Authors:  W Imagawa; E M Spencer; L Larson; S Nandi
Journal:  Endocrinology       Date:  1986-12       Impact factor: 4.736

7.  Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells.

Authors:  Irene H L Hamelers; Richard F M A van Schaik; Jorrit Sipkema; John S Sussenbach; Paul H Steenbergh
Journal:  J Biol Chem       Date:  2002-10-02       Impact factor: 5.157

8.  Local insulin-like growth factor-II mediates prolactin-induced mammary gland development.

Authors:  Russell C Hovey; Jessica Harris; Darryl L Hadsell; Adrian V Lee; Christopher J Ormandy; Barbara K Vonderhaar
Journal:  Mol Endocrinol       Date:  2002-12-23

9.  Acute effects of growth factors on T-47D breast cancer cell cycle progression.

Authors:  E A Musgrove; R L Sutherland
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

Review 10.  Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models.

Authors:  Robert L Sutherland; Elizabeth A Musgrove
Journal:  Breast Cancer Res       Date:  2001-11-30       Impact factor: 6.466

View more
  17 in total

Review 1.  The normal microenvironment directs mammary gland development.

Authors:  Erin J McCave; Cheryl A P Cass; Karen J L Burg; Brian W Booth
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-09-08       Impact factor: 2.673

2.  Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia.

Authors:  David L Kleinberg; Pietro Ameri; Baljit Singh
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

3.  Platelet-rich plasma increases proliferation of tendon cells by modulating Stat3 and p27 to up-regulate expression of cyclins and cyclin-dependent kinases.

Authors:  T-Y Yu; J-H S Pang; K P-H Wu; L-P Lin; W-C Tseng; W-C Tsai
Journal:  Cell Prolif       Date:  2015-05-25       Impact factor: 6.831

Review 4.  Reprogramming non-mammary and cancer cells in the developing mouse mammary gland.

Authors:  Robert D Bruno; Gilbert H Smith
Journal:  Semin Cell Dev Biol       Date:  2012-03-10       Impact factor: 7.727

5.  Prolactin potentiates transforming growth factor alpha induction of mammary neoplasia in transgenic mice.

Authors:  Lisa M Arendt; Teresa A Rose-Hellekant; Eric P Sandgren; Linda A Schuler
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

6.  Decreased IGF type 1 receptor signaling in mammary epithelium during pregnancy leads to reduced proliferation, alveolar differentiation, and expression of insulin receptor substrate (IRS)-1 and IRS-2.

Authors:  Zhaoyu Sun; Sain Shushanov; Derek LeRoith; Teresa L Wood
Journal:  Endocrinology       Date:  2011-05-31       Impact factor: 4.736

7.  Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals.

Authors:  Yaara Zwang; Aldema Sas-Chen; Yotam Drier; Tal Shay; Roi Avraham; Mattia Lauriola; Efrat Shema; Efrat Lidor-Nili; Jasmine Jacob-Hirsch; Ninette Amariglio; Yiling Lu; Gordon B Mills; Gideon Rechavi; Moshe Oren; Eytan Domany; Yosef Yarden
Journal:  Mol Cell       Date:  2011-05-20       Impact factor: 17.970

Review 8.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

9.  Reprogramming cell fates in the mammary microenvironment.

Authors:  Corinne A Boulanger; Gilbert H Smith
Journal:  Cell Cycle       Date:  2009-04-12       Impact factor: 4.534

10.  IGF-I, GH, and sex steroid effects in normal mammary gland development.

Authors:  David L Kleinberg; Weifeng Ruan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-25       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.